Article
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
World journal of gastroenterology - 14 Oct 2016
Takai Erina, Yachida Shinichi
Abstract excerpt
Most pancreatic cancer patients present with advanced metastatic disease, resulting in extremely poor 5-year survival, mainly because of the lack of a reliable modality for early detection and limited therapeutic options for advanced disease. Therefore, there is a need for minimally-invasive diagnostic tools for detecting pancreatic cancer at an early stage, when curative surgery and also novel therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
